Thrilled to share that Dr. Michael Nalappana, has successfully defended his doctoral dissertation! 🎉🎓
Michael’s research — “Evaluating the Receptor for Advanced Glycation End-Products (RAGE) as a Biomarker for Prostate Cancer Diagnosis and Treatment” — represents a meaningful step forward in our understanding of prostate cancer biology. His work explores RAGE as a potential diagnostic and therapeutic biomarker, opening new avenues for earlier detection and more targeted treatment of one of the most prevalent cancers in men worldwide.